Evidence map›Paper›PMID 18818254›Full record

Trial reportBMJ (Clinical research ed.)2008

Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial.

Helen R Murphy, Gerry Rayman, Karen Lewis, Susan Kelly, Balroop Johal, Katherine Duffield, Duncan Fowler, Peter J Campbell, Rosemary C Temple

5 registry-linked trialsAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMJ (Clinical research ed.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 5 registered trials, which are not on this map. Cited by 129 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 12 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02204657 nacompletednot on this mapstarted 2013, after this paper: background citation

The Effect of Professional Continuous Glucose Monitoring on Diabetes Management,Hypoglycemia and Glycemic Control in Insulin-requiring Gestational Diabetes Mellitus

TypeinterventionalSponsorUniversity of MalayaRan2013 to 2015Enrolled50ConditionsGestational Diabetes MellitusArmsContinuous Glucose Monitoring System
NCT03326232 naunknown statusnot on this mapstarted 2017, after this paper: background citation

Real-time Continuous Glucose Monitoring for the Treatment of Gestational Diabetes: a Randomized Trial

TypeinterventionalSponsorEastern Virginia Medical SchoolRan2017 to 2018Enrolled40ConditionsGestational DiabetesArmsContinuous glucose monitoring
NCT04099550 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Effect of Real-time Continuous Glucose Monitoring System in Overweight or Obese Adults With Prediabetes

TypeinterventionalSponsorPusan National University HospitalRan2019 to 2021Enrolled30ConditionsContinuous Glucose Monitoring, Prediabetic State, ObesityArmsRT-CGM, SMBG
NCT05317585 narecruitingnot on this mapstarted 2024, after this paper: background citation

Continuous Glucose Monitor Use and Perinatal Outcomes Among Pregnant Women With Type 2 Diabetes Mellitus: A Randomized Controlled Trial

TypeinterventionalSponsorUniversity of Massachusetts, WorcesterRan2024 to 2027Enrolled180ConditionsType 2 Diabetes Treated With Insulin, Pregnancy, High RiskArmsContinuous Glucose Monitor, Routine Capillary Blood Glucose Monitoring (Fingerstick Glucose)
NCT07184775 narecruitingnot on this mapstarted 2025, after this paper: background citation

Maternal Continuous Glucose Monitoring Surveillance Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes

TypeinterventionalSponsorThomas Jefferson UniversityRan2025 to 2026Enrolled70ConditionsType 2 Diabetes Mellitus (T2DM), Pregnancy, Continuous Glucose Monitoring SystemArmsContinuous glucose monitor, Glucometer
3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 12 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Continuous glucose monitoring systems for type 1 diabetes mellitus.The Cochrane database of systematic reviews · 2012
    Pooled it
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Helen R MurphyDepartment of Diabetes and Endocrinology, Ipswich Hospital NHS Trust, Ipswich IP4 5PD. Helen.Murphy@ipswichhospital.nhs.uk
Gerry Rayman
Karen Lewis
Susan Kelly
Balroop Johal
Katherine Duffield
Duncan Fowler
Peter J Campbell
Rosemary C Temple

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the effectiveness of continuous glucose monitoring during pregnancy on maternal glycaemic control, infant birth weight, and risk of macrosomia in women with type 1 and type 2 diabetes.

designProspective, open label randomised controlled trial.

settingTwo secondary care multidisciplinary obstetric clinics for diabetes in the United Kingdom.

participants71 women with type 1 diabetes (n=46) or type 2 diabetes (n=25) allocated to antenatal care plus continuous glucose monitoring (n=38) or to standard antenatal care (n=33).

interventionContinuous glucose monitoring was used as an educational tool to inform shared decision making and future therapeutic changes at intervals of 4-6 weeks during pregnancy. All other aspects of antenatal care were equal between the groups.

main outcome measuresThe primary outcome was maternal glycaemic control during the second and third trimesters from measurements of HbA(1c) levels every four weeks. Secondary outcomes were birth weight and risk of macrosomia using birthweight standard deviation scores and customised birthweight centiles. Statistical analyses were done on an intention to treat basis.

resultsWomen randomised to continuous glucose monitoring had lower mean HbA(1c) levels from 32 to 36 weeks' gestation compared with women randomised to standard antenatal care: 5.8% (SD 0.6) v 6.4% (SD 0.7). Compared with infants of mothers in the control arm those of mothers in the intervention arm had decreased mean birthweight standard deviation scores (0.9 v 1.6; effect size 0.7 SD, 95% confidence interval 0.0 to 1.3), decreased median customised birthweight centiles (69% v 93%), and a reduced risk of macrosomia (odds ratio 0.36, 95% confidence interval 0.13 to 0.98).

conclusionContinuous glucose monitoring during pregnancy is associated with improved glycaemic control in the third trimester, lower birth weight, and reduced risk of macrosomia.

trial registrationCurrent Controlled Trials ISRCTN84461581.

Indexed as

AdolescentAdultBlood GlucoseBlood Glucose Self-MonitoringDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2FemaleFetal MacrosomiaGlycated HemoglobinHumansHyperglycemiaMiddle AgedPregnancyPregnancy in DiabeticsPregnancy OutcomePrenatal CareBlood GlucoseGlycated Hemoglobin

Identifiers

PMID18818254
PMCPMC2563261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.